Alkem Laboratories Reports 14.62% Increase in Net Sales for March 2026 Quarter
Alkem Lab Consolidated March 2026 Net Sales at Rs 3,603.32 crore, up 14.62% Y-o-Y
Image: Moneycontrol
Alkem Laboratories announced a consolidated net sales figure of ₹3,603.32 crore for March 2026, reflecting a 14.62% year-on-year increase. However, net profit fell by 22.69% to ₹236.46 crore. The company's share price has decreased by 7.09% over the last six months.
- 01Net sales rose to ₹3,603.32 crore in March 2026 from ₹3,143.75 crore in March 2025.
- 02Net profit decreased to ₹236.46 crore in March 2026, down from ₹305.86 crore in the previous year.
- 03EBITDA increased by 33.54%, reaching ₹717.46 crore compared to ₹537.25 crore in March 2025.
- 04The earnings per share (EPS) fell to ₹19.77 from ₹25.57 in March 2025.
- 05Alkem's share price closed at ₹5,239.00 on June 1, 2026, with a 2.80% return over the last year.
Advertisement
In-Article Ad
Alkem Laboratories has reported consolidated net sales of ₹3,603.32 crore for the quarter ending March 2026, marking a 14.62% increase compared to ₹3,143.75 crore in March 2025. Despite this growth in sales, the company's net profit fell significantly by 22.69%, amounting to ₹236.46 crore, down from ₹305.86 crore in the same quarter last year. The earnings before interest, taxes, depreciation, and amortization (EBITDA) saw a notable rise of 33.54%, reaching ₹717.46 crore compared to ₹537.25 crore in the previous year. The earnings per share (EPS) also decreased to ₹19.77, down from ₹25.57. Alkem's shares were priced at ₹5,239.00 on June 1, 2026, reflecting a 7.09% decline over the past six months and a 2.80% increase over the last year.
Advertisement
In-Article Ad
The decline in net profit could affect investor confidence and stock performance, impacting market perceptions of Alkem Laboratories.
Advertisement
In-Article Ad
Reader Poll
How do you view Alkem Laboratories' recent financial performance?
Connecting to poll...
More about Alkem Laboratories
Alkem Laboratories Sees Major Stake Transactions Amid New Product Launch
The Economic Times • Jun 3, 2026
Alkem Laboratories Introduces Semaglutide Pre-Filled Syringes in India at ₹350
Business Standard • Jun 3, 2026
Alkem Laboratories Promoters Divest 1.5% Stake for ₹930 Crore
The Economic Times • Jun 2, 2026
Read the original article
Visit the source for the complete story.